GLYCOREX TRANSPLANTATION

Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, enables transplants across the blood group boundaries. This product has been used clinically since the fall of 2001 and enabled more than 3,500 blood group incompatible transplants with excellent clinical results. The company also develops products within universal blood plasma and products for specific treatment of autoimmune diseases, specifically Myasthenia gravis.